NCT06119139View on ClinicalTrials.gov

Anesthetic Efficacy of 1.8 ml Versus 3.6 ml of 4% Articaine Buccal Infiltration

NANot yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Symptomatic Irreversible Pulpitis
Interventions
DRUG

3.6 ml 4% Articaine hydrochloride

3.6 ml 4% articaine buccal infiltration

DRUG

1.8 ml 4% Articaine hydrochloride

1.8 ml 4% articaine buccal infiltration

All Listed Sponsors
lead

Cairo University

OTHER

NCT06119139 - Anesthetic Efficacy of 1.8 ml Versus 3.6 ml of 4% Articaine Buccal Infiltration | Biotech Hunter | Biotech Hunter